|
1
|
Medina J, Kantarjian H, Talpaz M, O'Brien
S, Garcia-Manero G, Giles F, Rios MB, Hayes K and Cortes J:
Chromosomal abnormalities in Philadelphia chromosome-negative
metaphases appearing during imatinib mesylate therapy in patients
with Philadelphia chromosome-positive chronic myelogenous leukemia
in chronic phase. Cancer. 98:1905–1911. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sive JI and Gottgens B: Transcriptional
network control of normal and leukaemic haematopoiesis. Exp Cell
Res. 329:255–264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen C, Chen MT, Zhang XH, Yin XL, Ning
HM, Su R, Lin HS, Song L, Wang F, Ma YN, et al: The PU.1-modulated
MicroRNA-22 is a regulator of monocyte/macrophage differentiation
and acute myeloid leukemia. PLoS Genet. 12:e10062592016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang S, Wang T, Li MZ, Cheng XL and Li XL:
Expression of microRNA miR-34a inhibits leukemia stem cells and its
metastasis. Eur Rev Med Pharmacol Sci. 20:2878–2883.
2016.PubMed/NCBI
|
|
5
|
Wang XS, Gong JN, Yu J, Wang F, Zhang XH,
Yin XL, Tan ZQ, Luo ZM, Yang GH, Shen C and Zhang JW: MicroRNA-29a
and microRNA-142-3p are regulators of myeloid differentiation and
acute myeloid leukemia. Blood. 119:4992–5004. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang TJ, Wang YX, Yang DQ, Yao DM, Yang
L, Zhou JD, Deng ZQ, Wen XM, Guo H, Ma JC, et al: Down-regulation
of miR-186 correlates with poor survival in de novo acute myeloid
leukemia. Clin Lab. 62:113–120. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin X, Wang Z, Wang Y and Feng W: Serum
MicroRNA-370 as a potential diagnostic and prognostic biomarker for
pediatric acute myeloid leukemia. Int J Clin Exp Pathol.
8:14658–14666. 2015.PubMed/NCBI
|
|
8
|
Wang YX, Zhang TJ, Yang DQ, Yao DM, Yang
L, Zhou JD, Deng ZQ, Ma JC, Guo H, Wen XM, et al: Reduced miR-215
expression predicts poor prognosis in patients with acute myeloid
leukemia. Jpn J Clin Oncol. 46:350–356. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oh B, Song H, Lee D, Oh J, Kim G, Ihm SH
and Lee M: Anti-cancer effect of R3V6 peptide-mediated delivery of
an anti-microRNA-21 antisense-oligodeoxynucleotide in a
glioblastoma animal model. J Drug Target. 25:132–139. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bastaminejad S, Taherikalani M, Ghanbari
R, Akbari A, Shabab N and Saidijam M: Investigation of MicroRNA-21
expression levels in serum and stool as a potential non-invasive
biomarker for diagnosis of colorectal cancer. Iran Biomed J.
21:106–113. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lv H, He Z, Wang H, Du T and Pang Z:
Differential expression of miR-21 and miR-75 in esophageal
carcinoma patients and its clinical implication. Am J Transl Res.
8:3288–3298. 2016.PubMed/NCBI
|
|
12
|
Yang B, Liu Z, Ning H, Zhang K, Pan D,
Ding K, Huang W, Kang XL, Wang Y and Chen X: MicroRNA-21 in
peripheral blood mononuclear cells as a novel biomarker in the
diagnosis and prognosis of prostate cancer. Cancer Biomark.
17:223–230. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li C, Zhao L, Chen Y, He T, Chen X, Mao J,
Li C, Lyu J and Meng QH: MicroRNA-21 promotes proliferation,
migration, and invasion of colorectal cancer, and tumor growth
associated with down-regulation of sec23a expression. BMC Cancer.
16:6052016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang XF, Zhang XW, Hua RX, Du YQ, Huang
MZ, Liu Y, Cheng YF and Guo WJ: Mel-18 negatively regulates stem
cell-like properties through downregulation of miR-21 in gastric
cancer. Oncotarget. 7:63352–63361. 2016.PubMed/NCBI
|
|
15
|
Nikiforova ZN, Taipov MA, Kudryavcev IA
and Shevchenko VE: The connection of miR-21 and miR-155 with
regulation of 15-HPGDH mRNA in human breast cancer cells. Biomed
Khim. 62:265–271. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meehan K and Vella LJ: The contribution of
tumour-derived exosomes to the hallmarks of cancer. Crit Rev Clin
Lab Sci. 53:121–131. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sabatel C, Malvaux L, Bovy N, Deroanne C,
Lambert V, Gonzalez ML, Colige A, Rakic JM, Noël A, Martial JA and
Struman I: MicroRNA-21 exhibits antiangiogenic function by
targeting RhoB expression in endothelial cells. PLoS One.
6:e169792011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou Y, Zhu Y, Zhang L, Wu T, Wu T, Zhang
W, Decker AM, He J, Liu J, Wu Y, et al: Human stem cells
overexpressing miR-21 promote angiogenesis in critical limb
ischemia by targeting CHIP to enhance HIF-1α activity. Stem Cells.
34:924–934. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jemal A, Thomas A, Murray T and Thun M:
Cancer statistics, 2002. CA Cancer J Clin. 52:23–47. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:pp. 2999–3004. 2004; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ni Z, Shang XF, Wang YF, Sun YJ and Fu DJ:
Upregulated microRNA-301a in osteosarcoma promotes tumor
progression by targeting CDC14A. Genet Mol Res. 15:2016. View Article : Google Scholar :
|
|
23
|
Li Y, Zhang B, Li W, Wang L, Yan Z, Li H,
Yao Y, Yao R, Xu K and Li Z: MiR-15a/16 regulates the growth of
myeloma cells, angiogenesis and antitumor immunity by inhibiting
Bcl-2, VEGF-A and IL-17 expression in multiple myeloma. Leuk Res.
49:73–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Xing QF, Liu XQ, Guo ZJ, Li CY and
Sun G: MiR-122 targets VEGFC in bladder cancer to inhibit tumor
growth and angiogenesis. Am J Transl Res. 8:3056–3066.
2016.PubMed/NCBI
|
|
25
|
Ji H, Li Y, Jiang F, Wang X, Zhang J, Shen
J and Yang X: Inhibition of transforming growth factor beta/SMAD
signal by MiR-155 is involved in arsenic trioxide-induced
anti-angiogenesis in prostate cancer. Cancer Sci. 105:1541–1591.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li H, Yuan SM, Yang M, Zha H, Li XR, Sun
H, Duan L, Gu Y, Li AF, Weng YG, et al: High intensity focused
ultrasound inhibits melanoma cell migration and metastasis through
attenuating microRNA-21-mediated PTEN suppression. Oncotarget.
7:50450–50460. 2016.PubMed/NCBI
|
|
28
|
Xiao J, Pan Y, Li XH, Yang XY, Feng YL,
Tan HH, Jiang L, Feng J and Yu XY: Cardiac progenitor cell-derived
exosomes prevent cardiomyocytes apoptosis through exosomal miR-21
by targeting PDCD4. Cell Death Dis. 7:e22772016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin L, Tu HB, Wu L, Liu M and Jiang GN:
MicroRNA-21 regulates non-small cell lung cancer cell invasion and
chemo-sensitivity through SMAD7. Cell Physiol Biochem.
38:2152–2162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cicchelero L, Denies S, Haers H,
Vanderperren K, Stock E, Van Brantegem L, de Rooster H and Sanders
NN: Intratumoural interleukin 12 gene therapy stimulates the immune
system and decreases angiogenesis in dogs with spontaneous cancer.
Vet Comp Oncol. 15:1187–1205. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dias S, Boyd R and Balkwill F: IL-12
regulates VEGF and MMPs in a murine breast cancer model. Int J
Cancer. 78:361–365. 1998. View Article : Google Scholar : PubMed/NCBI
|
